SCHEMBL24670073

SCHEMBL24670073

NCc1ccc(-c2ncc(Br)o2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
NPC1 O15118 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
ADRB2 P07550 1/20 0.43
LOXL2 Q9Y4K0 2/20 0.40
CYP2A6 P11509 1/20 0.40
TAAR1 Q96RJ0 2/20 0.39
ASIC3 Q9UHC3 1/20 0.39
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
CASP1 P29466 1/20 0.38
RAB9A P51151 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
AKT2 P31751 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28862553 0.79 KDM4E (0.45) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL84546 0.75 TSHR (0.59) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL69417 0.71 NPC1 (0.46) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL12102873 0.71 CYP4F2 (0.43) KDM4ENPC1ALDH1A1SMN1; SMN2TP53
SCHEMBL24670424 0.68 HRH3 (0.50) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL27807821 0.68 ADRB2 (0.62) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL27594199 0.67 LTA4H (0.50) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL22036434 0.67 NPC1 (0.65) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL26684345 0.67 NPC1 (0.53) KDM4ENPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL15240579 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022187693-A1 COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES UMBRA THERAPEUTICS INC. (US) 2022-09-09 WO disclosed